These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9652366)

  • 1. Comparison of the antiarrhythmic and the proarrhythmic effect of almokalant in anaesthetised rabbits.
    Farkas A; Leprán I; Papp JG
    Eur J Pharmacol; 1998 Apr; 346(2-3):245-53. PubMed ID: 9652366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
    Farkas A; Leprán I; Papp JG
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):287-97. PubMed ID: 11791015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of almokalant a specific inhibitor of IKr on myocardial ischaemia-reperfusion induced arrhythmias in rabbits.
    Farkas A; Leprán I; Papp JG
    Acta Physiol Hung; 1996; 84(3):281-2. PubMed ID: 9219607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of class III-induced proarrhythmias by flecainide in an animal model of the acquired long QT syndrome.
    Hallman K; Carlsson L
    Pharmacol Toxicol; 1995 Oct; 77(4):250-4. PubMed ID: 8577635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.
    Amos GJ; Abrahamsson C; Duker G; Hondeghem L; Palmer M; Carlsson L
    Cardiovasc Res; 2001 Feb; 49(2):351-60. PubMed ID: 11164845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias.
    Wiesfeld AC; Crijns HJ; Tobé TJ; Almgren O; Bergstrand RH; Aberg J; Haaksma J; Lie KI
    Am J Cardiol; 1992 Oct; 70(11):990-6. PubMed ID: 1384304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of proarrhythmias related to delayed repolarization by low-dose lidocaine in the anesthetized rabbit.
    Carlsson L; Drews L; Duker G; Schiller-Linhardt G
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1076-80. PubMed ID: 8263767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation.
    Lu HR; Remeysen P; De Clerck F
    J Cardiovasc Pharmacol; 2000 Dec; 36(6):728-36. PubMed ID: 11117372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological, rate dependent, and autonomic effects of the class III antiarrhythmic almokalant after myocardial infarction in the pig.
    Tuininga YS; De Langen CD; Crijns HJ; Wiesfeld AC; Mook PH; Bel KJ; Lie KI
    Pacing Clin Electrophysiol; 1996 May; 19(5):802-10. PubMed ID: 8734747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of extracardiac alpha1-adrenoceptor stimulation in assisting dofetilide to induce torsade de pointes in rabbit hearts.
    Farkas AS; Acsai K; Tóth A; Dézsi L; Orosz S; Forster T; Csanády M; Papp JG; Varró A; Farkas A
    Eur J Pharmacol; 2006 May; 537(1-3):118-25. PubMed ID: 16618484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions.
    Carlsson L; Almgren O; Duker G
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):276-85. PubMed ID: 1697384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gender-independent proarrhythmic action of 17beta-estradiol in anaesthetized rabbits.
    Philp KL; Hart G; Coker SJ
    Eur J Pharmacol; 2007 Dec; 575(1-3):113-21. PubMed ID: 17692839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
    Xue Y; Yamada C; Aye NN; Hashimoto K
    Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs.
    Végh A; Parratt JR
    Cardiovasc Res; 2002 Jul; 55(1):53-63. PubMed ID: 12062708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe.
    D'Alonzo AJ; Zhu JL; Darbenzio RB
    Eur J Pharmacol; 1999 Mar; 369(1):57-64. PubMed ID: 10204682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
    Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
    Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhythm anomalies related to delayed repolarization in vivo: influence of sarcolemmal Ca++ entry and intracellular Ca++ overload.
    Carlsson L; Drews L; Duker G
    J Pharmacol Exp Ther; 1996 Oct; 279(1):231-9. PubMed ID: 8858998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.